In vitro gastrointestinal lipolysis of four formulations of piroxicam and cinnarizine with the self emulsifying excipients Labrasol® and Gelucire® 44/14

Pharmaceutical Research

Volumn 26, Issue 8, 2009, Pages 1901-1910

  Fernandez, Sylvie ^a,b   Chevrier, Stéphanie ^b   Ritter, Nicolas ^b   Mahler, Bruno ^b   Demarne, Frédéric ^b   Carrière, Frédéric ^a   Jannin, Vincent ^b  

^a Centre National de la Recherche Scientifique   (France)

^b GATTEFOSSÉ SAS   (France)

Author keywords

Cinnarizine; Gastrointestinal lipolysis; Macrogolglycerides; Oral drug delivery; Piroxicam

Indexed keywords

CINNARIZINE; GELUCIRE; LABRASOL; PIROXICAM; TRIACYLGLYCEROL LIPASE;

ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG SOLUBILITY; DUODENUM; GASTROINTESTINAL TRACT; HYDROLYSIS; IN VITRO STUDY; LIPOLYSIS; PRECIPITATION; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CINNARIZINE; EXCIPIENTS; GASTROINTESTINAL TRACT; HISTAMINE H1 ANTAGONISTS; LIPOLYSIS; ORGANIC CHEMICALS; PIROXICAM; POLYETHYLENE GLYCOLS; SOLUBILITY;

EID: 67650034409     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-009-9906-2     Document Type: Article

References (55)

1. WN Charman CJH Porter S Mithani JB Dressman 1997 Physicochemical and physiological mechanisms for the effects of food on drug absorption: The role of lipids and pH J Pharm Sci 86 269 82 10.1021/js960085v
2. R Holm CJ Porter GA Edwards A Müllertz HG Kristensen WN Charman 2003 Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides Eur J Pharm Sci 20 91 7 10.1016/S0928-0987(03)00174-X
3. SM Khoo AJ Humberstone CJH Porter GA Edwards WN Charman 1998 Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine Int J Pharm 167 155 64 10.1016/S0378-5173(98)00054-4
4. S Nazzal II Smalyukh OD Lavrentovich MA Khan 2002 Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation Int J Pharm 235 247 65 10.1016/S0378-5173(02)00003-0
5. J Vonderscher A Meinzer 1994 Rationale for the development of Sandimmune Neoral Transplant Proc 26 2925 7
6. SA Charman WN Charman MC Rogge TD Wilson FJ Dutko CW Pouton 1992 Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound Pharm Res 9 87 93 10.1023/A:1018987928936
7. DQM Craig HSR Lievens KG Pitt DE Storey 1993 An investigation into the physico-chemical properties of self-emulsifying systems using low frequency dielectric spectroscopy, surface tension measurements and particle size analysis Int J Pharm 96 147 55 10.1016/0378-5173(93)90222-2
8. O Chambin V Jannin D Champion C Chevalier MH Rochat-Gonthier Y Pourcelot 2004 Influence of cryogenic grinding on properties of a self-emulsifying formulation Int J Pharm 278 79 89 10.1016/j.ijpharm.2004.02.033
9. SA Barker SP Yap KH Yuen CP McCoy JR Murphy DQM Craig 2003 An investigation into the structure and bioavailability of α-tocopherol dispersions in Gelucire 44/14 J Control Release 91 477 88 10.1016/S0168-3659(03) 00261-X
10. S Eaimtrakarn RYV Prasad T Ohno T Konishi Y Yoshikawa N Shibata K Takada 2002 Absorption enhancing effect of labrasol on the intestinal absorption of insulin in rats J Drug Target 10 255 60 10.1080/10611860290022688
11. DJ Hauss SE Fogal JV Ficorilli CA Price AA Jayaraj JJ Keirns 1998 Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor J Pharm Sci 87 164 9 10.1021/js970300n
12. Z Hu T Riichi K Takahiro S Nobuhito T Kanji 2001 A novel emulsifier, Labrasol, enhances gastrointestinal absorption of gentamicin Life Sci 69 2899 910 10.1016/S0024-3205(01)01375-3
13. S Hulsmann T Backensfeld S Keitel R Bodmeier 2000 Melt extrusion-an alternative method for enhancing the dissolution rate of 17-βestradiol hemihydrate Eur J Pharm Biopharm 49 237 42 10.1016/S0939-6411(00)00077-1
14. K Iwanaga T Kishibiki M Miyazaki M Kakemi 2006 Disposition of lipid-based formulation in the intestinal tract affects the absorption of poorly water-soluble drugs Biol Pharm Bull 29 508 12 10.1248/bpb.29.508
15. E Mehuys JP Remon A Korst L Van Bortel R Mols P Augustijns C Porter C Vervaet 2005 Human bioavailability of propranolol from a matrix-in-cylinder system with a HPMC-Gelucire® core J Control Release 107 523 36 10.1016/j.jconrel.2005.06.019
16. V Pillay R Fassihi 1999 A new method for dissolution studies of lipid-filled capsules employing nifedipine as a model drug Pharm Res 16 333 7 10.1023/A:1011959914706
17. YV Rama Prasad SP Puthli S Eaimtrakarn M Ishida Y Yoshikawa N Shibata K Takada 2003 Enhanced intestinal absorption of vancomycin with Labrasol and D-alpha-tocopheryl PEG 1000 succinate in rats Int J Pharm 250 181 90 10.1016/S0378-5173(02)00544-6
18. YV Rama Prasad T Minamimoto Y Yoshikawa N Shibata S Mori A Matsuura K Takada 2004 In situ intestinal absorption studies on low molecular weight heparin in rats using Labrasol as absorption enhancer Int J Pharm 271 225 32 10.1016/j.ijpharm.2003.11.013
19. N Yüksel A Karatas Y Özkan A Savaser SA Özkan T Baykara 2003 Enhanced bioavailability of piroxicam using Gelucire 44/14 and Labrasol: in vitro and in vivo evaluation Eur J Pharm Biopharm 56 453 9 10.1016/S0939- 6411(03)00142-5
20. GA Kossena BJ Boyd CJ Porter WN Charman 2003 Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs J Pharm Sci 92 634 48 10.1002/jps.10329
21. M Lindstrom H Ljusberg-Wahren K Larsson B Borgstrom 1981 Aqueous lipid phases of relevance to intestinal fat digestion and absorption Lipids 16 749 54 10.1007/BF02535343
22. S Fernandez V Jannin JD Rodier N Ritter B Mahler F Carriere 2007 Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol®, medium chain glycerides and PEG esters Biochim Biophys Acta 1771 633 40
23. S Fernandez JD Rodier N Ritter B Mahler F Demarne F Carrière V Jannin 2008 Lipolysis of the semi-solid self-emulsifying excipient Gelucire® 44/14 by digestive lipases Biochim Biophys Acta 1781 367 75
24. GL Amidon H Lennernas VP Shah JR Crison 1995 A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm Res 12 413 20 10.1023/A: 1016212804288
25. A Karatas N Yüksel T Baykara 2005 Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol Il Farmaco 60 777 82 10.1016/j.farmac.2005.04.014
26. GA Kossena WN Charman BJ Boyd CJH Porter 2004 A novel cubic phase of medium chain lipid origin for the delivery of poorly water soluble drugs J Control Release 99 217 29 10.1016/j.jconrel.2004.06.013
27. F Carriere JA Barrowman R Verger R Laugier 1993 Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans Gastroenterology 105 876 88
28. Lengsfeld H, Beaumier-Gallon G, Chahinian H, De CA, Verger R, Laugier R, et al. Physiology of gastrointestinal lipolysis and therapeutical uses of lipases and digestive lipase inhibitors. In: Müller G, Petry S, editors. Lipases and phospholipases in drug development. Weinheim: Wiley-VCH; 2004. p. 195-229.
29. S Bernback L Blackberg O Hernell 1989 Fatty acids generated by gastric lipase promote human milk triacylglycerol digestion by pancreatic colipase-dependent lipase Biochim Biophys Acta 1001 286 93
30. Y Gargouri G Pieroni C Riviere PA Lowe JF Sauniere L Sarda R Verger 1986 Importance of human gastric lipase for intestinal lipolysis : An in vitro study Biochim Biophys Acta 879 419 23
31. CJ De F Carriere P Barboni T Giller R Verger CA De 1998 Pancreatic lipase-related protein 1 (PLRP1) is present in the pancreatic juice of several species Biochim Biophys Acta 1387 331 41
32. CJ De B Sias P Grandval F Ferrato H Halimi F Carriere CA De 2004 Characterization of pancreatic lipase-related protein 2 isolated from human pancreatic juice Biochim Biophys Acta 1701 89 99 (Pubitemid 39140788)
33. T Giller P Buchwald D Blum-Kaelin W Hunziker 1992 Two novel human pancreatic lipase related proteins, hPLRP1 and hPLRP2. Differences in colipase dependence and in lipase activity J Biol Chem 267 16509 16
34. C Eydoux CJ De F Ferrato P Boullanger D Lafont R Laugier F Carriere CA De 2007 Further biochemical characterization of human pancreatic lipase-related protein 2 expressed in yeast cells J Lipid Res 48 1539 49 10.1194/jlr.M600486- JLR200
35. D Lombardo J Fauvel O Guy 1980 Studies on the substrate specificity of a carboxyl ester hydrolase from human pancreatic juice. I. Action on carboxyl esters, glycerides and phospholipids Biochim Biophys Acta 611 136 46
36. L Sek CJ Porter WN Charman 2001 Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis J Pharm Biomed Anal 25 651 61 10.1016/S0731-7085(00)00528-8
37. L Sek CJ Porter AM Kaukonen WN Charman 2002 Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products J Pharm Pharmacol 54 29 41 10.1211/0022357021771896
38. F Carriere H Moreau Y Gargouri C Cudrey F Ferrato A Bernadac C Bénicourt JL Junien R Verger 1991 Human gastric lipase GBF Monograph 16 129 33
39. F Carriere S Bezzine R Verger 1997 Molecular evolution of the Pancreatic lipase and two related enzymes towards different substrate selectivities J Mol Catal B: Enzymatic 3 55 64 10.1016/S1381-1177(96)00049-5
40. MW Bodmer S Angal GT Yarranton TJ Harris A Lyons DJ King G Pieroni C Riviere R Verger PA Lowe 1987 Molecular cloning of a human gastric lipase and expression of the enzyme in yeast Biochim Biophys Acta 909 237 44
41. S Vaganay G Joliff O Bertaux E Toselli MD Devignes C Benicourt 1998 The complete cDNA sequence encoding dog gastric lipase DNA Seq 8 257 62 10.3109/10425179809008461
42. A Roussel S Canaan MP Egloff M Riviere L Dupuis R Verger C Cambillau 1999 Crystal structure of human gastric lipase and model of lysosomal acid lipase, two lipolytic enzymes of medical interest J Biol Chem 274 16995 7002 10.1074/jbc.274.24.16995
43. A Roussel N Miled L Berti-Dupuis M Riviere S Spinelli P Berna V Gruber R Verger C Cambillau 2002 Crystal structure of the open form of dog gastric lipase in complex with a phosphonate inhibitor J Biol Chem 277 2266 74 10.1074/jbc.M109484200
44. MM Bradford 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 248 54 10.1016/0003-2697(76)90527-3
45. F Carriere C Renou V Lopez CJ De F Ferrato H Lengsfeld CA De R Laugier R Verger 2000 The specific activities of human digestive lipases measured from the in vivo and in vitro lipolysis of test meals Gastroenterology 119 949 60 10.1053/gast.2000.18140
46. J Jinno DM Oh JR Crison GL Amidon 2000 Dissolution of ionizable water-insoluble drugs: the combined effect of pH and surfactant J Pharm Sci 89 268 74 10.1002/(SICI)1520-6017(200002)89:2<268::AID-JPS14>3.0.CO;2-F
47. CH Gu D Rao RB Gandhi J Hilden K Raghavan 2005 Using a novel multicompartment dissolution system to predict the effect of gastric pH on the oral absorption of weak bases with poor intrinsic solubility J Pharm Sci 94 199 208 10.1002/jps.20242
48. CW Pouton CJH Porter 2008 Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies Adv Drug Deliv Rev 60 625 37 10.1016/j.addr.2007.10.010->
49. P Finholt S Solvang 1968 Dissolution kinetics of drugs in human gastric juice-the role of surface tension J Pharm Sci 57 1322 6 10.1002/jps.2600570809
50. JB Dressman GL Amidon C Reppas VP Shah 1998 Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms Pharm Res 15 11 22 10.1023/A:1011984216775
51. E Galia J Horton JB Dressman 1999 Albendazole generics-a comparative in vitro study Pharm Res 16 1871 5 10.1023/A:1018907527253
52. M Vertzoni E Pastelli D Psachoulias L Kalantzi C Reppas 2007 Estimation of intragastric solubility of drugs: in what medium? Pharm Res 24 909 17 10.1007/s11095-006-9209-9
53. D Lairon G Nalbone H Lafont J Leonardi N Domingo JC Hauton R Verger 1978 Possible roles of bile lipids and colipase in lipase adsorption Biochem 17 5263 9 10.1021/bi00617a028
54. DG Fatouros GR Deen L Arleth B Bergenstahl FS Nielsen JS Pedersen A Mullertz 2007 Structural development of self nano emulsifying drug delivery systems (SNEDDS) during in vitro lipid digestion monitored by small-angle X-ray scattering Pharm Res 24 1844 53 10.1007/s11095-007-9304-6
55. DG Fatouros B Bergenstahl A Mullertz 2007 Morphological observations on a lipid-based drug delivery system during in vitro digestion Eur J Pharm Sci 31 85 94 10.1016/j.ejps.2007.02.009